医薬品微生物検査キットの世界市場レポート 2025年

医薬品微生物検査キット市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で107億8,000万米ドルに成長します。予測期間の成長は、医薬品微生物検査における自動化利用の増加、医薬品微生物検査研究開発への投資の増加、医薬品微生物検査における新技術の採用拡大、バイオ医薬品製造、個別化医療に起因します。予測期間における主な動向には、迅速微生物検査、ポイントオブケア検査、シングルユースシステム、デジタル統合、バイオセーフティとバイオセキュリティなどがあります。

医薬品微生物検査キット市場は、世界の感染症の急増に後押しされています。CDCが強調しているように、A型肝炎、B型肝炎、C型肝炎、性病、HIVなどの疾病が増加しています。2021年、WHOの報告書は、世界中で年間約140万人のA型肝炎患者が発生していることを指摘しています。感染針注射、無防備な性行為、ホームレス、限られた医療アクセスなどの要因が感染症の症例増加の一因となっており、医薬品微生物検査キットの需要を促進しています。

ヘルスケア支出の増加は、医薬品微生物検査キット市場を促進すると予想されます。ヘルスケア支出には、個人、組織、政府が特定期間中にヘルスケア関連の商品やサービスに費やした総額が含まれます。ヘルスケア支出の増加は医薬品微生物検査キットの需要増につながります。医療施設は包括的な感染対策に投資するからです。その結果、患者の安全と規制基準の遵守を確保するために、微生物汚染物質や病原体の検査がより頻繁に行われるようになります。例えば、2023年11月、カナダに本部を置く非営利団体Canadian Institute for Health Informationは、2023年の総医療費が3,440億米ドルに達し、前年比2.8％の緩やかな成長となると予測しました。従って、医療費の増加は医薬品微生物検査キット市場の成長を牽引することになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医薬品微生物検査キット PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品微生物検査キット市場：成長率分析
• 世界の医薬品微生物検査キット市場の実績：規模と成長, 2019-2024
• 世界の医薬品微生物検査キット市場の予測：規模と成長, 2024-2029, 2034F
• 世界医薬品微生物検査キット総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品微生物検査キット市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• 装置
• 世界の医薬品微生物検査キット市場テストによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• エンドトキシン検査
• 無菌試験
• 微生物検査
• 環境モニタリング
• その他のテスト
• 世界の医薬品微生物検査キット市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診断センター
• カスタムラボサービスプロバイダー
• 学術調査機関
• 世界の医薬品微生物検査キット市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 培地と試薬
• 検査キット
• サンプル収集容器
• 世界の医薬品微生物検査キット市場、機器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インキュベーター
• オートクレーブ
• 微生物同定システム

第7章 地域別・国別分析

• 世界の医薬品微生物検査キット市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品微生物検査キット市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品微生物検査キット市場：競合情勢
• 医薬品微生物検査キット市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Toxikon Corp.
• Pace Analytical Services
• Boston Analytics
• Charles River Laboratories International
• Nelson Laboratories
• Siemens Healthcare AG
• Hologic Inc.
• Neogen Corporation
• Shimadzu Corporation
• Merck KGaA
• Agilent Technologies Inc.
• QIAGEN N.V.
• Bruker Corporation
• bioMerieux SA
• Lucideon

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品微生物検査キット市場2029：新たな機会を提供する国
• 医薬品微生物検査キット市場2029：新たな機会を提供するセグメント
• 医薬品微生物検査キット市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharma microbiology testing kits play a critical role in identifying contamination and maintaining high standards in pharmaceuticals. These kits are instrumental in detecting microbial limits in drugs, vaccines, and other biologics.

The primary products within pharma microbiology testing kits include consumables and equipment. Consumables are used specifically for detecting microbial limits in pharmaceutical products. These kits facilitate various tests such as endotoxin testing, sterility testing, microbial examination, environmental monitoring, among others. These testing procedures cater to end-users such as hospitals, diagnostic centers, custom lab service providers, academic institutions, and research institutes.

The pharma microbiology testing kits market research report is one of a series of new reports from The Business Research Company that provides pharma microbiology testing kits market statistics, including pharma microbiology testing kits industry global market size, regional shares, competitors with a pharma microbiology testing kits market share, detailed pharma microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the pharma microbiology testing kits industry. This pharma microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma microbiology testing kits market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing demand for pharmaceuticals, increasing prevalence of infectious diseases, rising globalization, rising awareness of the importance of pharma microbiology testing, globalization of pharmaceutical production.

The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $10.78 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing use of automation in pharma microbiology testing, rising investment in pharma microbiology testing research and development, growing adoption of new technologies in pharma microbiology testing, biopharmaceutical manufacturing, personalized medicine. Major trends in the forecast period include rapid microbial testing, point-of-care testing, single-use systems, digital integration, biosafety and biosecurity.

The pharma microbiology testing kits market is being propelled by the surge in infectious diseases globally. Diseases like Hepatitis A, B, and C, STDs, and HIV are on the rise, as highlighted by the CDC. In 2021, The WHO report noted approximately 1.4 million annual cases of Hepatitis A worldwide. Factors such as infected needle injections, unprotected sex, homelessness, and limited medical access contribute to the escalating instances of infectious diseases, thereby driving the demand for pharma microbiology testing kits.

The rising healthcare expenditure is expected to advance the pharma microbiology testing kits market. Healthcare expenditure encompasses the total amount spent by individuals, organizations, or governments on healthcare-related goods and services over a specific period. An increase in healthcare spending leads to a higher demand for pharma microbiology testing kits, as healthcare facilities invest in comprehensive infection control measures. This results in more frequent testing for microbial contaminants and pathogens to ensure patient safety and compliance with regulatory standards. For instance, in November 2023, the Canadian Institute for Health Information, a nonprofit organization based in Canada, projected that total health expenditure would reach $344 billion in 2023, representing a modest growth of 2.8% compared to the previous year. Therefore, the increase in healthcare expenditure will drive growth in the pharma microbiology testing kits market.

Contracting out routine microbiological testing to specialized laboratories is gaining traction within the pharma microbiology testing kits market. This outsourcing strategy ensures stringent quality and safety standards for raw materials, intermediates, and end products. Contract testing labs manage various testing domains like stability testing, method validation, microbial testing, and batch-release testing. Notably, the global healthcare analytical testing market is projected to reach $4.13 billion by 2021, growing at an 11.3% rate, signaling the expanding reliance on outsourcing for such services.

Major companies in the pharma microbiology testing kits market are increasingly adopting innovative technologies, such as artificial intelligence (AI), to enhance operational efficiency. The use of AI to improve operational efficiency involves leveraging intelligent technologies to boost business performance, streamline processes, reduce costs, and facilitate better decision-making through automation and data analysis. For example, in May 2023, Becton, Dickinson, and Company, a medical device firm based in the U.S., received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new BD Kiestra MRSA Imaging Application. This application employs artificial intelligence to improve the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA). It automates the inspection of Petri dishes, a process that has traditionally been labor-intensive and time-consuming, by analyzing bacterial growth on BBL CHROMagar MRSA II plates. The application can swiftly identify specimens that exhibit no significant growth, thereby expediting the processing and release of negative results.

In November 2022, IDEXX, a healthcare innovation company based in the US, acquired Tecta-PDS for an undisclosed sum. This strategic acquisition aims to broaden IDEXX's presence in the field of water microbiology testing. Tecta-PDS, headquartered in Canada, specializes in water microbiology testing services.

Major companies operating in the pharma microbiology testing kits market include F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMerieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation

North America was the largest region in the pharma microbiology testing kits market in 2024. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharma microbiology testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Microbiology Testing Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma microbiology testing kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma microbiology testing kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma microbiology testing kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Equipment
• 2) By Test: Endotoxin Testing; Sterility Testing; Microbial Examination; Environmental Monitoring; Other Tests
• 3) By End User: Hospitals & Diagnostic Centers; Custom Lab Service Providers; Academic & Research Institutes
• Subsegments:
• 1) By Consumables: Media and Reagents; Test Kits; Sample Collection Containers
• 2) By Equipment: Incubators; Autoclaves; Microbial Identification Systems
• Companies Mentioned: F. Hoffmann-La Roche AG; Becton Dickinson and Company; Abbott Laboratories; ThermoFisher Scientific; SGS SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma Microbiology Testing Kits Market Characteristics

3. Pharma Microbiology Testing Kits Market Trends And Strategies

4. Pharma Microbiology Testing Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharma Microbiology Testing Kits Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharma Microbiology Testing Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharma Microbiology Testing Kits Market Growth Rate Analysis
• 5.4. Global Pharma Microbiology Testing Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharma Microbiology Testing Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharma Microbiology Testing Kits Total Addressable Market (TAM)

6. Pharma Microbiology Testing Kits Market Segmentation

• 6.1. Global Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Equipment
• 6.2. Global Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endotoxin Testing
• Sterility Testing
• Microbial Examination
• Environmental Monitoring
• Other Tests
• 6.3. Global Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals & Diagnostic Centers
• Custom Lab Service Providers
• Academic & Research Institutes
• 6.4. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Media and Reagents
• Test Kits
• Sample Collection Containers
• 6.5. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Incubators
• Autoclaves
• Microbial Identification Systems

7. Pharma Microbiology Testing Kits Market Regional And Country Analysis

• 7.1. Global Pharma Microbiology Testing Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharma Microbiology Testing Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma Microbiology Testing Kits Market

• 8.1. Asia-Pacific Pharma Microbiology Testing Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma Microbiology Testing Kits Market

• 9.1. China Pharma Microbiology Testing Kits Market Overview
• 9.2. China Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma Microbiology Testing Kits Market

• 10.1. India Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma Microbiology Testing Kits Market

• 11.1. Japan Pharma Microbiology Testing Kits Market Overview
• 11.2. Japan Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma Microbiology Testing Kits Market

• 12.1. Australia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma Microbiology Testing Kits Market

• 13.1. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma Microbiology Testing Kits Market

• 14.1. South Korea Pharma Microbiology Testing Kits Market Overview
• 14.2. South Korea Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma Microbiology Testing Kits Market

• 15.1. Western Europe Pharma Microbiology Testing Kits Market Overview
• 15.2. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma Microbiology Testing Kits Market

• 16.1. UK Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma Microbiology Testing Kits Market

• 17.1. Germany Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma Microbiology Testing Kits Market

• 18.1. France Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma Microbiology Testing Kits Market

• 19.1. Italy Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma Microbiology Testing Kits Market

• 20.1. Spain Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma Microbiology Testing Kits Market

• 21.1. Eastern Europe Pharma Microbiology Testing Kits Market Overview
• 21.2. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma Microbiology Testing Kits Market

• 22.1. Russia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma Microbiology Testing Kits Market

• 23.1. North America Pharma Microbiology Testing Kits Market Overview
• 23.2. North America Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma Microbiology Testing Kits Market

• 24.1. USA Pharma Microbiology Testing Kits Market Overview
• 24.2. USA Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma Microbiology Testing Kits Market

• 25.1. Canada Pharma Microbiology Testing Kits Market Overview
• 25.2. Canada Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma Microbiology Testing Kits Market

• 26.1. South America Pharma Microbiology Testing Kits Market Overview
• 26.2. South America Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma Microbiology Testing Kits Market

• 27.1. Brazil Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma Microbiology Testing Kits Market

• 28.1. Middle East Pharma Microbiology Testing Kits Market Overview
• 28.2. Middle East Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma Microbiology Testing Kits Market

• 29.1. Africa Pharma Microbiology Testing Kits Market Overview
• 29.2. Africa Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma Microbiology Testing Kits Market Competitive Landscape And Company Profiles

• 30.1. Pharma Microbiology Testing Kits Market Competitive Landscape
• 30.2. Pharma Microbiology Testing Kits Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Pharma Microbiology Testing Kits Market Other Major And Innovative Companies

• 31.1. Toxikon Corp.
• 31.2. Pace Analytical Services
• 31.3. Boston Analytics
• 31.4. Charles River Laboratories International
• 31.5. Nelson Laboratories
• 31.6. Siemens Healthcare AG
• 31.7. Hologic Inc.
• 31.8. Neogen Corporation
• 31.9. Shimadzu Corporation
• 31.10. Merck KGaA
• 31.11. Agilent Technologies Inc.
• 31.12. QIAGEN N.V.
• 31.13. Bruker Corporation
• 31.14. bioMerieux SA
• 31.15. Lucideon

32. Global Pharma Microbiology Testing Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma Microbiology Testing Kits Market

34. Recent Developments In The Pharma Microbiology Testing Kits Market

35. Pharma Microbiology Testing Kits Market High Potential Countries, Segments and Strategies

• 35.1 Pharma Microbiology Testing Kits Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharma Microbiology Testing Kits Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharma Microbiology Testing Kits Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer